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Summary: 
This study investigates the non-specific immunological effects of DTP and measles 
vaccination of healthy African infants. The results indicate sex-differential effects on 
both innate and adaptive immunity, providing the first mechanistic insights into how 
these vaccines alter infectious disease susceptibility.   
 
ABSTRACT  
Vaccines can have non-targeted heterologous effects which manifest as increased 
protection against non-vaccine infections, as described for measles vaccine (MV); or 
increased susceptibility to infections and death, as described following diphtheria-
tetanus-whole cell pertussis (DTP) vaccination. The mechanisms are unknown and 
high quality immunological studies are lacking. This study was designed to 
investigate the heterologous effects of MV and DTP in 302 Gambian infants.  The 
results support an immunosuppressive effect of DTP on innate pro-inflammatory 
responses and T cell immunity in females. Males but not females receiving MV had 
enhanced pro-inflammatory innate responses. The results point to modified signalling 
via Toll-like re eptor (TLR4) as a possible mechanism for the effects on innate 
immunity. When both vaccines were administered together, PPD responses were 
enhanced in females but down-regulated in males. Collectively these data indicate 
immunological effects that could account for heterologous effects of MV and DTP, to 
take forward into prospective trials.  
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INTRODUCTION 
Background 
Multiple epidemiological studies have described heterologous effects of vaccines on 
infectious disease susceptibility and all-cause mortality [1-4]. Bacille Calmette-
Guérin (BCG) vaccinated low-birth-weight neonates had a 45% lower all-cause 
mortality compared to unvaccinated controls in a randomized trial conducted in 
Guinea Bissau [5]; and an additional early measles vaccine (MV) at 4.5 months was 
associated with reduced mortality in the absence of measles infections in a 
randomized trial in Guinea-Bissau [6]. A recent population-level data analysis 
suggested that MV protects against all-cause mortality by preventing prolonged 
immunosuppression caused by wild type measles infection [7]. However, if true, then 
censoring for measles infection should prevent beneficial effects of MV, which is not 
the case in numerous epidemiological studies [8].   
 
A review of all available studies where mortality was assessed in the context of 
diphtheria-tetanus-whole cell pertussis (DTP) vaccination suggests that DTP is 
associated with increased mortality, particularly in females [9]. Several observational 
studies suggest that receiving DTP with MV is associated with higher mortality 
compared to receiving MV only, with males generally more susceptible [10, 11].  
 
A systematic review for non-specific effects of vaccines commissioned by WHO 
concluded that the epidemiological evidence supports beneficial heterologous effects 
of MV; but found insufficient evidence to confirm or refute deleterious heterologous 
effects of DTP [12], although the analytical principles used have been questioned 
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[13]. The need to explore and understand the immunological mechanisms was 
emphasized in the WHO review.  
 
We used state-of-the-art methodology to elucidate the immunological mechanisms 
that might account for beneficial effects of MV and deleterious effects of DTP in a 
prospective randomized trial, and further analysed the effect of administering both 
vaccines simultaneously.  
 
METHODS 
Study Subjects 
Infants attending for routine vaccination were recruited at four months of age at 
Sukuta Health Centre, a peri-urban area 20 km from the coast of The Gambia. 
Eligibility criteria included being healthy, apyrexial (<37.5°C), normal weight-for-
age, and all recommended vaccines received to date. The study was approved by the 
Joint Gambia Government/MRC Ethics Committee (project number SCC1085). 
Written informed consent was provided by the parent/guardian of the child. 
 
Study Design  
Four month old infants were block randomized to one of three vaccine groups in a 
prospective unblind d study. At 4 months of age group 1 received their third dose of 
diphtheria-tetanus-whole cell pertussis (DTP), hepatitis B vaccine (HBV) and oral 
polio vaccine (OPV); and groups 2 and 3 received HBV and OPV only. At nine 
months of age group 1 received a single standard intramuscular (i.m.) dose of measles 
vaccine (MV) (Edmonston Zagreb strain, Serum Institute of India Ltd., Pune, India); 
group 2 received MV and i.m. DTP (Serum Institute of India Ltd.); and group 3 
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received DTP alone. Outstanding vaccines were administered at 11 months of age 
(Supplementary Table 1). Venous blood was collected at nine months immediately 
before vaccination and 4 weeks later: 4.5mLs into a heparinized tube (7.5 units 
heparin/mL); 0.5mL into a PaxgeneTM tube (Qiagen, Crawley, UK). 
 
Whole blood cultures 
Heparinized whole blood was cultured in 100μL aliquots in 96-well U-bottom plates 
with tetanus toxoid (TT) (10μg/ml, Sanofi Pasteur, France); purified protein derivative 
(PPD) (10μg/mL, Statens Serum Institute, Denmark); a measles peptide-pool of 122 
15mer peptides overlapping by 10 amino acids spanning measles protein 
haemagglutinin (all 1g/mL final concentration, Sigma-Genosys, UK); heat-killed 
listeria monocytogenes (HKLM) (109 cells/mL) (TLR2 agonist); E. coli K12 
lipopolysaccharide protein S (LPS) (1μg/mL) (TLR4 agonist); flagellin (10μg/mL) 
(TLR5 agonist); and CLO-75 (10μg/mL) (TLR7/8 agonist) (all from InvivoGen, San 
Diego, USA). Anti-CD3 (αCD3) (5μg/mL, Becton-Dickinson (BD), USA) and anti-
CD28 (αCD28) (5μg/mL, eBiosciences, UK) were used as a general T cell stimulus, 
and medium alone was the negative control. Plates were incubated for 16 hours at 
37°C, 5% CO2, centrifuged at 2,000 rpm for 5 minutes and 50μL supernatant collected 
and stored at -20°C. 
 
Multiplex cytokine assays for plasma and culture supernatants 
The Bio-Plex 200 Suspension Array system (Bio-Rad, Hercules, California, USA) 
was used to analyze cytokines according to the manufacturer’s instructions (Bio-Rad, 
Belgium). A human 27-plex array (Bio-plex Pro Human Cytokine 27-plex 
Immunoassay for fibroblast growth factor basic [FGF basic], eotaxin, granulocyte-
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colony-stimulating factor [G-CSF], granulocyte macrophage-CSF [GM-CSF], 
interferon-gamma [IFN-γ], interleukin-1beta [IL-1β], IL-1ra, IL-2, IL-4, IL-5, IL-6, 
IL-7, IL-8, IL-9, IL-10, IL-12(p70), IL-13, IL-15, IL-17, interferon-gamma-inducible 
protein-10 [IP-10], melanocortin receptor-1 [MCR-1], macrophage inflammatory 
protein-1 alpha [MIP-1, MIP-1β, platelet derived growth factor-BB [PDGF-BB], 
regulated on activation, normal T cell expressed and secreted [RANTES], tumour 
necrosis factor [TNF], vascular endothelial growth factor [VEGF]) or a customized 
10-plex array (IL-1β, IL-4, IFN-γ, IL-10, IL-12(p70), eotaxin, GM-CSF, PDGF-BB, 
TNF, VEGF) was used to analyse cytokines in plasma samples (n=214 infants), and 
cytokines in cultures with vaccine related (TT, Measles Pool) and non-related (PPD, 
αCD3/αCD28) antigens (n=192 infants). For TLR agonist stimulations, a 5-plex array 
(IL-1β, IL-6, IL-10, IL-12(p70), TNF) was used (n=122 infants). Assays were not 
performed for all infants due to insufficient blood volume, clotted or contaminated 
blood samples. Medium background values were subtracted from antigen-stimulated 
values to establish net cytokine production. Cytokine ratios were analysed without 
background correction. 
 
MV and DTP vaccine antibodies 
A multiplex microsphere based fluorescent immunoassay for diphtheria toxoid (Dtx), 
tetanus toxoid (Ttx) and pertussis toxoid (Ptx) IgG antibodies was performed at the 
National Institute of Public Health and the Environment (RIVM), Netherlands using 
published protocols [14] (n=284 infants). The measles IgG haemagglutination 
inhibition assay (HAI) was performed using monkey red blood cells as previously 
described [15] (n=283 infants).  
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Statistical analysis of antibody and cytokine data 
Cytokine and antibody variables were analysed by fitting a linear mixed model using 
restricted maximum likelihood. Bleed, group and sex, and their interactions were 
fitted as fixed effects and infant, and sample within infant, were fitted as random 
effects. The F-test was used to test for 2-way group-by-bleed and 3-way sex-by-
group-by-bleed interactions. Comparisons between treatment groups, and sexes 
within treatment groups, at each time point, were based on t-tests utilizing the 
predicted means and standard errors of differences recovered from the fitted mixed 
model.  Comparisons were conducted at 5% significance with no adjustments for 
multiple comparisons. Cytokine and antibody data required logarithmic 
transformation prior to analysis. Data were analysed using GenStat 17 (VSN 
International), R 3.1.2 (www.r-project.org) and Stata version 12.1 (StataCorp LP, 
USA).  
 
Whole blood RNA microarray analysis 
RNA was extracted from PaxgeneTM tubes using PAXgeneTM blood RNA extraction 
kits (Qiagen, Crawley, UK) according to manufacturer’s instructions. 100ng RNA 
was used to generate labeled cRNA using the Ambion Illumina TotalPrep-96 RNA 
Amplification Kit. cRNA was hybridized to Human HT-12 V3 microarrays (Illumina) 
comprising 47,293 features. 348 RNA samples from 183 infants (165 infants with 
paired samples) were deemed of sufficient quality for analysis using the array Quality 
Metrics pa kage in Bioconductor [16]. Raw data were transformed using a variance 
stabilizing transformation (VST) prior to normalization across all arrays using the 
robust spline normalization (RSN) method. Eighteen manually chosen comparisons 
for differentially expressed genes were undertaken using an empirical Bayesian 
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approach (post- compared to pre- for each vaccine group, for all donors and by sex, 
for unpaired and paired data). The Benjamini-Hochberg p value adjustment for 
multiple testing was implemented in limma software package for R, to control for 
false discovery rate. The resulting gene list was fully annotated and sorted in order of 
decreasing significance. Functional enrichment analysis was performed using KEGG 
pathway (www.genome.jp/kegg/) membership (raw p<0.01, enrichment p<0.05), and 
Gene Ontology (GO) terms (www.geneontology.org) (raw p<0.01, enrichment 
p<0.001). Networks were laid out for all relationships exhibiting a Pearson correlation 
greater than 0.75. MCL clustering of nodes was undertaken (expansion value 1.7), 
and functional analysis of each cluster performed using public and proprietary 
databases. Expression networks were constructed employing the Ingenuity Pathway 
Analysis (IPA) software (Ingenuity Systems, www.ingenuity.com). 
 
RESULTS 
Cohort characteristics 
302 children were randomized at four months of age into vaccine groups (Fig. 1). 
Ethnic mix was comparable in the 3 vaccine groups (Table 1). Weight-for-age z 
scores, haemoglobin and platelet counts were comparable in all groups and sexes 
(Table 1). MV+DTP males had significantly higher total white cell counts and 
significantly lower lymphocyte counts after vaccination compared to other groups, 
although 3-way interactions were not significant. Local HIV seroprevalence [17] and 
helminth infection rates were low [18] and unlikely to be significant confounders. 
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Vaccine IgG levels  
The expected induction of IgG antibodies to measles occurred in the MV and MV+DTP 
groups and not the DTP group (Fig. 2A and B). Similarly, diphtheria, tetanus and 
pertussis toxoid responses were boosted in the DTP and MV+DTP groups, but not the 
MV group (Fig. 2C-H). Females had higher Ptx antibody levels than males post-
vaccination (p=0.01) (Figs. 2G and H), but there were no other sex differences. 
 
Plasma cytokine profiles post-vaccination  
Plasma cytokine group differences were found for TNF:IL-10, IFN-γ:IL-10, IL-7, 
PDGF and IP-10 (Fig. 3). The DTP group had significantly lower IL-7 than the MV 
group (p=0.029) (Fig. 4A). The DTP group had lower TNF:IL-10 than the other 
vaccine groups whether for all donors combined, males or females (Fig. 4B). IFN-
γ:IL-10 ratios were also lower in DTP males and females, with high levels in 
MV+DTP females (Fig. 4C). MV males had higher TNF:IL-10 and IFN-γ:IL-10 
(p=0.039) than MV females (p=0.011). DTP females had lower IP-10 than DTP males 
(p=0.037) and MV females (p=0.021) (Fig. 4D). PDGF levels were generally higher 
in the DTP vaccinated group, and MV females (Fig. 4E).  
 
Toll-like receptor agonist responses 
Cytokine responses were tested to TLR2, 4, 5 and 7/8 in vitro stimulation, but only 
TLR4 (LPS) responses changed following vaccination. The DTP group had lower 
post-vaccination TNF production following LPS stimulation than the MV group 
(p=0.049) (Figs. 5A).  The MV males but not females had increased TNF (p=0.003)  
and increased TNF:IL-10 (p=0.008) in LPS cultures post- compared to pre-
vaccination (Fig. 5B and 5C). In addition, LPS stimulated TNF:IL-10 was 
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significantly higher in MV males compared to both DTP and MV+DTP males at 10 
months (p=0.013 and 0.021, respectively) (Fig. 5C), but this was not observed in 
females.  
 
Vaccine-specific cellular responses  
Priming of measles-specific cellular responses occurred in the MV and MV+DTP but 
not DTP groups, with upregulation of IFN-γ:IL-10 and IFN-γ:IL-4 to the measles 
peptide pool post-vaccination (Fig. 6A). TT reactivity was low and not boosted in the 
DTP vaccinated infants for any of the cytokines tested (not shown). There was no 
evidence of any sex interaction in measles or tetanus specific in vitro reactivity.  
 
Cytokine responses to T cell stimulation  
Broad T cell reactivity was assessed by αCD3/αCD28 stimulation. Levels of 
αCD3/αCD28 stimulated eotaxin declined significantly in the MV+DTP group post-
vaccination (p<0.001); and post-vaccination levels of eotaxin were lower in this group 
than the MV (p=0.001) and the DTP groups (p=0.009) (Fig. 6B). 
 
DTP vaccinated females had significantly lower IL-12(p70) levels than males post-
vaccination (p=0.022) but not pre-vaccination (p=0.626) (Fig. 6C). Anti-CD3/αCD28 
stimulated IFN-γ:IL-4 declined significantly in the DTP group post-vaccination 
(p=0.029), and post-vaccination levels were lower in the DTP group compared to the 
MV (p=0.008) and MV+DTP groups (p=0.005) (Fig. 6D). The MV+DTP males had 
significantly increased αCD3/αCD28 stimulated IFN-γ:IL-4 post-vaccination 
(p=0.042) (Fig. 6E); and DTP vaccinated females had significantly lower IFN-γ:IL-4 
than males at 10 months (p=0.002) but not baseline (p=0.451) (Fig. 6F). 
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Reactivity to the unrelated antigen PPD  
Significant sex-by-bleed-by-group interactions were found for TNF (p=0.001), 
eotaxin (p=0.004) and IL-10 (p=0.032) following PPD stimulation. For all 3 cytokines 
the PPD responses were equivalent in males and females at baseline, but increased 
significantly in MV+DTP females from pre to post-vaccination (p=0.048, 0.02 and 
0.043, respectively) (Figs. 7A, C, E), while decreasing in MV+DTP males (p=0.002, 
0.024 and 0.016, respectively) (Figs. 7B, D, F). MV males had significantly increased 
TNF following PPD stimulation post compared to pre-vaccination (p=0.019) (Fig. 
7B) whereas females did not (Fig. 7A).  
 
Differential whole human genome RNA expression profiles  
Ex-vivo gene expression profiles were analysed to gain further insights into 
mechanisms of heterologous effects of MV and DTP. While a series of significantly 
differentially expressed genes were identified (Fig. 8A), after multiple test adjustment 
only 2 showed statistically significant genes (MV females paired and unpaired - 1 
probe of unknown function). Therefore, a less stringent explorative approach 
accepting a high rate of false discovery was taken. Genes were filtered by fold-change 
expression post-vaccination compared to pre-vaccination for each group for paired 
and unpaired data for all donors and males and females separately identifying 70 
differentially expressed probes with ≥1.5 fold (up- or down-regulated) in one or more 
groups (Supplementary Table 2). There was no differential expression ≥1.5 fold 
unless vaccine treatment groups were separated by sex. Heat maps of the 70 
differentially expressed probes were generated, and clustered by genes and conditions 
using Pearson’s dissimilarity (Fig. 8B).  
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There were 29 probes ≥1.5 fold down-regulated in DTP vaccinated females, the 
majority being type 1 interferon stimulated genes involved in pattern recognition of 
pathogens and interferon signalling (Table 2). Ingenuity Pathway Analysis suggested 
down-regulated interferon signalling and dendritic cell (DC) maturation pathways 
(Fig. 9A), and the gene ontology terms implicated were recognition of viruses and 
bacteria. By contrast, DTP vaccinated males had 18 probes ≥1.5 fold up-regulated 
(Table 2). One major network was produced consisting of up-regulated functions 
associated with developmental pathways, RNA transcription complex and post-
transcriptional modification pathways (Fig. 9B). The top canonical pathway functions 
were up-regulated assembly of RNA polymerase II complex, T-cell receptor 
signalling and protein kinase A signalling; the major associated functions being genes 
involved in developmental and repair functions (Table 2).  
 
While DTP vaccinated males had exclusively up-regulated genes, males vaccinated 
with MV+DTP had only down-regulated genes (Table 2, Fig. 9C). The top canonical 
pathway associated functions were for down-regulated amino acid metabolism and 
signalling processes. There were insufficient differentially expressed genes among 
MV males and females and MV+DTP females to perform pathway analysis.  
 
DISCUSSION 
This is the first longitudinal randomized trial designed specifically to study for 
heterologous effects of vaccination with MV, DTP or both together. Lower post-
vaccination pro-inflammatory responses to TLR4 stimulation in DTP vaccinated 
infants implies impaired innate immunity to gram-negative bacteria, whereas responses 
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to TLR2, TLR5 and TLR7/8 were unaffected. BCG vaccination enhances TLR4 
reactivity via epigenetic upregulation of NOD2 activity on macrophages, which in turn 
increases pro-inflammatory responses to unrelated pathogens [19]. Therefore a 
plausible mechanism for DTP-induced TLR4 inhibitory effects is via epigenetic 
modulation. The tentative down-regulation of predominantly type 1 interferon genes in 
DTP vaccinated females but not males further supports this theory, since the STAT1 
pathway, which is strongly dependent on type 1 interferons, is a pivotal mechanism for 
‘trained immunity’ leading to altered innate memory [20].  
 
DTP vaccinated females also had suppressed T cell reactivity, as evidenced by 
decreased αCD3/αCD28 stimulated type 1 cytokines following vaccination. Vaccines 
may influence T cell responses to unrelated pathogens via induction of cross-reactive T 
cells that can either be protective or harmful [21]; but suppression of reactivity to anti-
CD3/anti-CD28 stimulation suggests a more generalized suppression of T cell 
immunity. Lower plasma IL-7 in DTP vaccinated infants, a haematopoietic growth 
factor that plays an important role in T and B cell development and survival [22], 
could further cause impaired cellular immunity.  
 
These broad immunosuppressive effects of DTP vaccination, particularly in females, 
could account for increased susceptibility to infections and all-cause mortality 
following DTP [9, 13]. That these effects were not significant when MV was given 
with DTP suggests co-administration of the live measles vaccine modifies the 
immunosuppressive effects of DTP.  
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Measles vaccination provides beneficial heterologous effects, particularly in females, 
via unknown mechanisms [6, 8]. In our study, the major MV effect was in males who 
had more pro-inflammatory plasma and enhanced TLR4 reactivity following 
vaccination. Therefore modified TLR4 reactivity is major candidate mechanism for 
heterologous effects of both MV and DTP. Plasma IP-10 was higher in MV females, a 
Th1 biasing chemokine with a role in effector T cell trafficking [24], but also known 
to predict severity of a number of inflammatory diseases [25].  
 
Reactivity to the mycobacterial antigen PPD can be due to BCG vaccination and 
priming by environmental mycobacteria [26]. Enhanced PPD responses in MV+DTP 
females, and down-regulated in MV+DTP males, suggest that when the vaccines are 
given together, females immunity becomes more reactive, while males become less 
so. In keeping with this was down-regulation of several cellular proliferation and 
growth genes in MV+DTP vaccinated males but not females. MV+DTP males also 
had higher WBC and lower lymphocytes than other groups post-vaccination, 
suggesting a bone marrow effect. Negative effects in males concurs with 
epidemiological data suggesting males may be more susceptible than females to 
adverse heterologous effects following administration of MV with DTP [10, 11]. 
 
Our results highlight the importance of analysing for sex interactions. Males and 
females are immunologically skewed in opposite directions due to sex hormones, 
most evident during puberty, but also in infancy [27, 28]. The X-chromosome 
contains numerous immune response genes and micro-RNAs contributing to 
immunological sex differences [29, 30].  
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Several limitations should be noted. Samples were taken at a single time point post-
vaccination, and immune dynamics may differ in the sexes. Plasma was only analysed 
at 10 months but not baseline. The MV group received an additional DTP at four 
months of age compared to the other two groups. Differentially expressed genes did 
not reach statistical significance after correction for multiple testing and a less 
stringent analysis approach was taken.  
 
Our data provide further evidence that vaccines educate both innate and adaptive 
immunity in previously unsuspected ways [2, 21]. We have identified plausible 
immunological effects at the protein level underscoring the heterologous effects of MV 
and DTP vaccines and their sex-differential nature, and differentially expressed genes 
that might be explored as targets of these vaccine effects. The epigenetic effects of 
DTP and MV on TLR4 signalling should be explored to investigate for negative and 
positive innate ‘immune training’ effects. It will also be crucial to investigate the 
mechanism of suppressed T cell signalling in DTP vaccinated females. The effects of 
hormones and X-linked immune response genes could also be explored. The public 
health implications of understanding these vaccine effects are enormous since they 
could be exploited in future vaccine design. Furthermore, minor changes to vaccine 
schedules could maximize beneficial and minimize deleterious effects of vaccines [32].  
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Figure Legends 
 
Figure 1 Participant numbers and drop outs 
302 infants were randomized at 4 months of age to vaccine groups, 16 of whom 
dropped out of the study before the first bleed at 9 months of age. Adequate blood 
samples were obtained from 273 of the 286 vaccinated infants (95.5%) prior to 
vaccination at 9 months of age, and 254 (93%) at 10 months of age. Numbers tested 
in each assay in the different vaccine groups are indicated. Blood volumes were often 
limited and not all assays could be performed on each sample.  
 
Figure 2 Measles and DTP antibody titres before and after vaccination in 
females and males 
Measles (in log2 HAI titres), diphtheria toxoid (Dtx, IU / mL), tetanus toxoid (Ttx, IU 
/ mL), and pertussis toxoid (Ptx, EU / mL) IgG levels for males (left panels A, C, E, 
G) and females (right panels B, D, F, H). Mean values are indicated by the horizontal 
bar. *** indicates p<0.001 from the fitted linear mixed model of log transformed 
mean antibody values for Dtx, Ttx and Ptx and the logit for measles HAI. HAI = 
haemagglutination inhibition assay. The horizontal dotted line indicates protective Ab 
titre cutoff, but ther  is no accepted protective level for Ptx titres (results are shown 
for n=283 infants for MV Abs and n=284 infants for DTP Abs). 
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Figure 3  Summary of vaccine group differences in post-vaccination plasma 
cytokine levels 
The figure summarizes where significant differences were found in post-vaccination 
plasma cytokine levels between vaccine groups for all donors combined (All), males 
(M) and females (F) showing that for IL-7, TNF:IL-10, IFN-γ:IL-10 and IP-10 the 
DTP group generally had lower levels than other vaccine groups, whereas for PDGF 
the DTP group generally had higher levels. 
 
Figure 4 Plasma cytokine levels at 10 months of age 
Plasma cytokine levels were measured at 10 months of age, 4 weeks after the study 
vaccines were administered. No baseline analysis was performed. The figure shows 
results for IL-7(A) and TNF:IL-10 ratios (B), IFN-γ:IL-10 ratios (C), IP-10 (D), and 
PDGF (E). A fitted linear mixed model of log transformed cytokine values was used 
to determine significant differences by vaccine group and sex. * p<0.05, ** p<0.01. 
The height of the bar indicates the mean value, the error bars indicate SEM (results 
are shown for n=214 infants). 
 
Figure 5 Cytokine responses in vitro to TLR agonist stimulation 
Infant whole blood was cultured overnight at 9 and 10 months with TLR2, 4, 5 and 
7/8 agonists. Only pro-inflammatory responses to LPS (TLR4 agonist) were altered 
following vaccination: the TNF response to LPS in all donors combined (A); and the 
TNF (B) and TNF:IL-10 ratios (C) in males only. A fitted linear mixed model of log 
transformed cytokine values was used to determine significant differences by vaccine 
group, bleed and sex. * p<0.05, ** p<0.01. The height of the bar indicates the mean 
value, the error bars indicate SEM (results are shown for n=122 infants). 
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Figure 6 Cytokine responses to measles peptides and αCD3/αCD28 stimulation in 
vitro 
Infant whole blood was cultured overnight at 9 and 10 months with a measles peptide 
pool or the general T cell stimulus αCD3/αCD28 and cytokines measured in culture 
supernatants. Measles-specific responses were stimulated in the MV and MV+DTP 
groups, but not the DTP alone group (A). A significant group-by-bleed interaction 
was found for eotaxin responses to αCD3/αCD28 (B); and there were significant sex-
by-group-by-bleed interactions in αCD3/αCD28 cultures for IL-12(p70) (C) and IFN-
γ:IL-4 ratios (D-F). A fitted linear mixed model of log transformed cytokine values 
was used to determine significant differences by vaccine group, bleed and sex. * 
p<0.05, ** p<0.01, ***p<0.001. The height of the bar indicates the mean value, the 
error bars indicate SEM (results are shown for n=192 infants). 
 
Figure 7 Cytokine responses to PPD stimulation in vitro 
Infant whole blood was cultured overnight at 9 and 10 months with the recall antigen 
PPD and cytokines measured in culture supernatants. There was a significant group-
by-sex-by-bleed interaction for raw TNF (A, B), IL-10 (C, D), and eotaxin (E, F). 
Female responses are shown in the right hand panels and male responses on the left. 
Asterisks indicate a significant interaction from the fitted linear mixed model of log 
transformed cytokine values, * p<0.05, ** p<0.01. The height of the bar indicates the 
mean value, the error bars indicate SEM (results are shown for n=192 infants). 
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Figure 8 Analysis for differentially expressed probes in the vaccine groups 
(A) A significance landscape was plotted for the 5,915 non-redundant significant 
genes (x-axis) by comparisons (y-axis). The number of significantly altered genes in 
each comparison are shown in parentheses after the comparison description. 
Comparisons with the highest number of significant changes are shown at the bottom. 
F = females, M = males, P = paired analysis, where no M or F are shown the analysis 
is for males and females combined, where no P is shown the analysis is for unpaired 
data. (B) Hierarchical clustering of the 70 probes with ≥1.5-fold differential 
expression post-vaccination compared to pre-vaccination organized by vaccine group 
(left hand y-axis) where purple indicates females and males combined, pink indicates 
females, and pale blue indicates males. Pairs of data are shown for each group – the 
upper set representing paired data (P) and the lower set shows unpaired (U) data from 
all donors. Genes are clustered by Pearson dissimilarity as shown above, values are 
displayed as log2 fold change in expression. For both panels red = up-regulated, blue 
= down-regulated, grey = non-significant or no change. Results shown are for n=183 
infants.  
 
Figure 9 Networks of differentially expressed genes in males and females in the 
DTP and MV+DTP groups 
Differentially expressed genes and their associated pathways following DTP 
vaccination of infant females (A) or males (B), and MV+DTP vaccination of males 
(C). Networks were generated using Ingenuity Pathway Analysis software. Green 
nodes indicate down-regulated genes, and red nodes indicate up-regulated genes. 
There were insufficient differentially expressed genes to generate pathways for the 
MV males and females, and the MV+DTP females. 
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  MV Group MV+DTwP Group DTwP Group   
  Female Male Female Male Female Male 
Total 
No. 
No. randomised at 4 months 48 58 56 59 37 44 302 
No. infants bled at 9 months 42 55 51 53 32 40 273 
No. infants bled at 10 months 36 53 48 49 33 35 254 
Weight-for-age z-score at 4 mths 
 0.22  
(-0.56-0.72) 
 0.20  
(-0.46-1.00) 
 -0.09  
(-0.71-0.92) 
 0.07  
(-0.63-0.8) 
 -0.33  
(-0.89-0.28) 
 0.16  
(-0.46-1.02) 
 Ethnicity of mother        
 Mandinka 38 (79.2%) 42 (72.4%) 47 (83.9%) 41 (69.5%) 27 (75.7%) 29 (65.9%) 
 Wolof 1 5 3 3 2 3 
 Fula 3 6 3 7 5 5 
 Jola 3 2 0 3 1 3 
 Other 3 3 3 5 2 4 
 Haemoglobin (g/dL)       
 9 months 10.2 (9.3-10.8) 10.2 (9.2-11.1) 9.9 (8.7-10.9) 9.8 (8.9-10.9) 10.1 (9.6-10.5) 10.0 (9.4-10.7) 
 10 months 10.3 (8.9-10.8) 9.6 (8.6-10.7) 9.5 (8.5-10.2) 9.4 (8.5-10.1) 10.0 (9.0-10.4) 9.7 (8.9-10.4) 
 White blood cells (x103/L)       
 
9 months 
8.4  
(7.0-10.6) 
7.8  
(5.3-9.8) 
8.8  
(7.3-11.4) 
8.7  
(6.7-12.1) 
9.9  
(7.1-11.1) 
9.2  
(6.3-10.2) 
 
10 months 
9.1  
(7.2-11.1) 
9.3  
(7.7-12.3) 
9.0  
(6.9-10.7) 
11.3  
(8.3-13.4)* 
8.8  
(6.8-11.4) 
9.0  
(7.0-11.7) 
 Lymphocytes (%)       
 
9 months 
63.4  
(52.4-68.0) 
61.1  
(55.8-67.8) 
64.8  
(59.6-72.1) 
62.3  
(60.5-66.4) 
62.6  
(56.3-69.0) 
63.4  
(50.0-69.1) 
  66.2  63.7  65.5  59.4  65.5  66.0  
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pt10 months (61.7-73.9) (56.8-67.7) (59.2-70.5) (46.8-66.4)* (51.6-71.2) (61.9-68.4) Platelets (x109/L)        9 months 165 (104-265) 141 (103-251) 197 (135-272) 183 (121-267) 178 (144-265) 208 (122-263) 
 10 months 163 (108-279) 162 (106-234) 153 (123-206) 177 (118-263) 146 (98-252) 196 (126-298)   
No. infants tested in the study assays 
      Measles antibodies 44 56 55 54 35 39 283 
DTP antibodies 45 55 56 55 35 38 284 
Plasma cytokines 32 44 42 43 28 25 214 
10-plex culture supernatants 30 35 35 34 28 30 192 
5-plex culture supernatants 23 21 22 25 15 16 122 
Transcriptome 31 33 30 32 26 31 183 
 
Median and IQ range shown for weight and blood parameters. The donor numbers tested for some assays are higher than the numbers at each 
bleed because some infants attended for 1 bleed and not the other. The bold text indicates a significant difference in the indicated group 
compared to other groups. 
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Change 
DTP Vaccinated Females 
IFIT2 
Interferon-induced protein with 
tetratricopeptide repeats 2 
Interferon signaling 
Cell-mediated immune 
response, Antiviral activity 
-2.297 
RSAD2 
Radical S-adenosyl methionine domain 
containing 2 
Pattern Recognition 
Receptors in Recognition of 
Bacteria and Viruses 
Cell-mediated immune 
response, Response to 
virus 
-2.144 
IFIT1 
Interferon-induced protein with 
tetratricopeptide repeats 1 
Interferon Signaling 
Molecular Transport, 
Antiviral defense, Innate 
immunity 
-2 
IFIT3 
Interferon-induced protein with 
tetratricopeptide repeats 3 
Interferon signaling 
Antiviral defense, Innate 
immunity 
-1.986 
HERC5 
HECT and RLD domain containing E3 
ubiquitin protein ligase 5 
Protein modification; protein 
ubiquitination 
Post-translational 
modification 
-1.945 
IFI44 Interferon-induced protein 44 
Activation of IRF by 
Cytosolic Pattern 
Recognition Receptors 
Response to virus -1.905 
ISG15 ISG15 ubiquitin-like modifier 
RIG-I-like receptor signaling 
pathway; Interferon 
signaling 
Antiviral response -1.84 
OAS3 2'-5'-oligoadenylate synthetase 3 Interferon signaling Antiviral response -1.828 
IFITM3 Interferon induced transmembrane protein 3 Interferon signaling Response to virus -1.828 
IFI44L Interferon-induced protein 44-like Interferon signaling 
Immune response; defense 
response to virus 
-1.828 
DTP Vaccinated males 
ADD3 Adducin 3 (gamma) 
Activation of cAMP-
Dependent PKA 
Hematological System 
Development and Function; 
Tissue Morphology 
1.625 
 at B
odleian Library on July 22, 2016
http://cid.oxfordjournals.org/
D
ow
nloaded from
 
Ac
ce
pte
d M
an
us
cri
ptJMJD1C Jumonji domain containing 1C Leukocyte Extravasation Signaling Hematopoiesis 1.58 MST4 Serine/threonine protein kinase MST4 Apoptotic pathway Cellular Growth and 
Proliferation 
1.58 
ANKRD10 ankyrin repeat domain 10 N/A N/A 1.558 
ZFAND5 Zinc finger, AN1-type domain 5 
TNF-alpha/NF-kB Signaling 
Pathway; FoxO family 
signaling 
N/A 1.558 
DR1 
Down-regulator of transcription 1, TBP-
binding (negative cofactor 2) 
Chromatin Regulation / 
Acetylation 
Assembly of RNA 
Polymerase II Complex 
1.548 
OSBPL8 Oxysterol binding protein-like 8 N/A N/A 1.548 
RASGRP1 
RAS guanyl releasing protein 1 (calcium and 
DAG-regulated) 
Gαs Signaling, T cell 
receptor signaling pathway 
Hematological System 
Development and Function; 
Cellular Development 
1.548 
PRNP Prion protein Prion diseases 
Cellular Development; Cell 
Death and Survival 
1.537 
BNIP3L 
BCL2/adenovirus E1B 19kDa interacting 
protein 3-like 
Apoptosis Cancer; Induces apoptosis 1.526 
MV+DTP Vaccinated Males 
SMOX Spermine oxidase 
Amine and polyamine 
degradation; spermine 
degradation 
Regulation of polyamine 
intracellular concentration 
-1.647 
DPYSL5 Dihydropyrimidinase-like 5 Axon guidance Neural development -1.636 
DVL1 Dishevelled, dsh homolog 1 (Drosophila) 
Wnt signaling pathway, 
Notch signaling pathway, 
Pathways in cancer 
Regulation of cell 
proliferation, Cancer, 
Dermatological conditions 
-1.613 
RNF213 Ring finger protein 213 
Protein modification; protein 
ubiquitination. 
Ubiquitin-protein ligase 
activity 
-1.58 
SPRYD3 SPRY domain containing 3 N/A N/A -1.548 
TPRA1 
Transmembrane protein, adipocyte 
asscociated 1 
G-protein coupled receptor 
signaling pathway 
Small Molecule 
Biochemistry 
-1.537 
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ptMUC6 Mucin 6, oligomeric mucus/gel-forming N/A Tissue Development -1.526 ARTN Artemin N/A Cellular growth and proliferation -1.516 
ADRA2C Adrenergic, alpha-2C, receptor 
Neuroactive ligand-receptor 
interaction 
Nervous system 
development and function 
-1.516 
IGFBP1 Insulin-like growth factor binding protein 1 
Insulin receptor signaling 
pathway 
Cellular growth and 
proliferation 
-1.505 
 
The top 10 differentially expressed genes are shown for each group 
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